Fiorentino, F.P.;                     Marchesi, I.;                     Schröder, C.;                     Schmidt, R.;                     Yokota, J.;                     Bagella, L.    
        BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. Int. J. Mol. Sci. 2020, 21, 9595.
    https://doi.org/10.3390/ijms21249595
    AMA Style
    
                                Fiorentino FP,                                 Marchesi I,                                 Schröder C,                                 Schmidt R,                                 Yokota J,                                 Bagella L.        
                BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 2020; 21(24):9595.
        https://doi.org/10.3390/ijms21249595
    
    Chicago/Turabian Style
    
                                Fiorentino, Francesco Paolo,                                 Irene Marchesi,                                 Christoph Schröder,                                 Ronny Schmidt,                                 Jun Yokota,                                 and Luigi Bagella.        
                2020. "BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells" International Journal of Molecular Sciences 21, no. 24: 9595.
        https://doi.org/10.3390/ijms21249595
    
    APA Style
    
                                Fiorentino, F. P.,                                 Marchesi, I.,                                 Schröder, C.,                                 Schmidt, R.,                                 Yokota, J.,                                 & Bagella, L.        
        
        (2020). BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells. International Journal of Molecular Sciences, 21(24), 9595.
        https://doi.org/10.3390/ijms21249595